The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going in 2026?

This clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in ...

This biotech firm develops targeted oncology therapies and leverages proprietary technology to address tumor resistance ...

Two biotech stocks, Ligand Pharmaceuticals and United Therapeutics, are showing resilient action in Friday's stock market.

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

Despite world-class AI-biotech research, a Nobel Prize-winning protein design lab and proximity to global AI expertise, Washington's life sciences sector is still learning to tell its story.

Robertet has invested in Aethera Biotech to boost its expertise in biotech and grow its health and beauty division. The ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Biotech skincare could offer a competitive edge when targeted and personalised skincare is concerned. Here is what you need ...

When federal immigration officers fanned out across Minneapolis for months, many immigrant families hunkered down at home and watched their paychecks disappear. Now, one of Minnesota’s wealthiest ...